Proposed Acquisitions, Earnings Release Schedule, Divestitures, Price Movements, and Financial Results - Analyst Notes on BioFuel, Albemarle, Cabot, Olin, and Senomyx

NEW YORK, April 3, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding BioFuel Energy Corp. (NASDAQ: BIOF), Albemarle Corp. (NYSE: ALB), Cabot Corp. (NYSE: CBT), Olin Corp. (NYSE: OLN), and Senomyx Inc. (NASDAQ: SNMX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

--

BioFuel Energy Corp. Analyst Notes 

On March 28, 2014, BioFuel Energy Corp. (BioFuel) announced that Greenlight Capital, Inc. and James R. Brickman have given the Company a preliminary non-binding proposal for a possible transaction. The terms pursuant to which, one or more newly-formed, wholly owned subsidiaries of the Company would acquire all of the equity interests of JBGL Capital, LP and JBGL Builder Finance, LLC, and their direct and indirect subsidiaries. The Board of Directors of BioFuel will establish a special committee consisting of independent directors to evaluate the Proposal and alternatives for the Company. The full analyst notes on BioFuel Energy Corp. are available to download free of charge at:

http://www.AnalystsReview.com/04032014/BIOF/report.pdf

--

Albemarle Corp. Analyst Notes 

On March 24, 2014, Albemarle Corp. (Albemarle) announced the schedule of its upcoming earnings release. The Company will report its Q1 2014 financial results after NYSE closes on April 16, 2014, Wednesday. The Company will host a conference call to discuss the results on April 17, 2014, Thursday at 9:00 a.m. ET. The webcast can be accessed through Thomson's password-protected event management site, Streetevents.com. The full analyst notes on Albemarle Corp. are available to download free of charge at:

http://www.AnalystsReview.com/04032014/ALB/report.pdf

--

Cabot Corp. Analyst Notes 

On March 20, 2014, Cabot Corp. (Cabot) announced that it had agreed to divest its Security Materials business to SICPA for approximately $20 million in cash. "We are pleased to have reached an agreement with SICPA at an attractive value for our shareholders," said Patrick Prevost, Cabot President and CEO. "The Security Materials business is a leader in covert taggant technology. We believe that SICPA, as a leading player in the security industry, will expand and accelerate the future growth potential of this business." SICPA is the leading global provider of security inks, authentication and traceability solutions and services for banknotes, security documents and consumer products. The full analyst notes on Cabot Corp. are available to download free of charge at:

http://www.AnalystsReview.com/04032014/CBT/report.pdf

--

Olin Corp. Analyst Notes 

On March 31, 2014, Olin Corp.'s (Olin) stock increased 3.02% to end the day at $27.61, compared to the previous day's closing price of $26.80. The Company's stock went up 5.41% over the past one trading month, compared to the Dow Jones Industrial Average which increased 0.22% and to the Standard & Poor's 500 which declined 0.25% during the same trading period. The full analyst notes on Olin Corp. are available to download free of charge at:

http://www.AnalystsReview.com/04032014/OLN/report.pdf

--

Senomyx Inc. Analyst Notes 

On March 14, 2014, Senomyx, Inc. (Senomyx) reported its Q4 2013 and full-year 2013 financial results. For the quarter, total revenues were $7.4 million compared to $8.2 million in Q4 2012. Net loss was $0.08 per share, compared to $0.06 per share for Q4 2012. For full year 2013, the Company reported total revenues of $29.3 million, compared to $31.2 million in 2012. Net loss was $0.29 per share in 2013, compared to $0.23 per share in 2012. "Senomyx continues to maintain a healthy balance sheet, and we began 2014 with nearly $33 million in cash and no debt. We are well-positioned to achieve our discovery, development and commercialization objectives, and we have no plans to raise money through the issuance of equity or debt to fund the current scope of our operations," said Tony Rogers, Senior Vice President and CFO. For full year 2014, the Company anticipates total revenues of $32 million to $35 million and net loss of $0.23 to $0.28 per share. The full analyst notes on Senomyx Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04032014/SNMX/report.pdf

--

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

--

=============

EDITOR NOTES: 

• This is not company news. We are an independent source and our views do not reflect the companies mentioned.
• Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
• This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
• If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
• For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
• Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE 

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE 

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED 

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED